Feng Biosciences Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Out of Business

  • Employees
  • 21

Employees

  • Latest Deal Type
  • Out of Business

  • Financing Rounds
  • 7

Feng Biosciences General Information

Description

Developer of cancer therapies intended to improve the long-term survival of cancer patients worldwide. The company's proprietary, precision, RNA-based biomarker platform offers immunomodulatory monoclonal antibodies combined with immune checkpoint inhibitors, enabling healthcare providers to deliver effective therapies for cancer patients to improve their survival chances.

Contact Information

Website
www.fengbiosciences.com
Formerly Known As
OncXerna Therapeutics
Ownership Status
Out of Business
Financing Status
Formerly PE-Backed
Corporate Office
  • 300 Fifth Avenue
  • Suite 6040
  • Waltham, MA 02451
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 300 Fifth Avenue
  • Suite 6040
  • Waltham, MA 02451
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Feng Biosciences Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Feng Biosciences‘s full profile, request access.

Request a free trial

Feng Biosciences Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of cancer therapies intended to improve the long-term survival of cancer patients worldwide. The company's pro
Drug Discovery
Waltham, MA
21 As of 2023

South San Francisco, CA
 

Kalamazoo, MI
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Feng Biosciences Competitors (28)

One of Feng Biosciences’s 28 competitors is Iconic Therapeutics, a Formerly VC-backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Iconic Therapeutics Formerly VC-backed South San Francisco, CA
Metabolic Solutions Development Company Venture Capital-Backed Kalamazoo, MI
Alnylam Pharmaceuticals Formerly VC-backed Cambridge, MA
CervoMed Formerly VC-backed Boston, MA
Cognition Therapeutics Formerly VC-backed New York, NY
You’re viewing 5 of 28 competitors. Get the full list »

Feng Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Feng Biosciences FAQs

  • When was Feng Biosciences founded?

    Feng Biosciences was founded in 2018.

  • Where is Feng Biosciences headquartered?

    Feng Biosciences is headquartered in Waltham, MA.

  • What is the size of Feng Biosciences?

    Feng Biosciences has 21 total employees.

  • What industry is Feng Biosciences in?

    Feng Biosciences’s primary industry is Drug Discovery.

  • Is Feng Biosciences a private or public company?

    Feng Biosciences is a Private company.

  • What is Feng Biosciences’s current revenue?

    The current revenue for Feng Biosciences is .

  • How much funding has Feng Biosciences raised over time?

    Feng Biosciences has raised $167M.

  • Who are Feng Biosciences’s competitors?

    Iconic Therapeutics, Metabolic Solutions Development Company, Alnylam Pharmaceuticals, CervoMed, and Cognition Therapeutics are some of the 28 competitors of Feng Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process